NCT01516983: Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation |
|
|
| Completed | 1/2 | 15 | RoW | icotinib, BPI-2009, Conmana, Whole brain radiotherapy, RT, XRT, Radiotherapy, WBRT | Betta Pharmaceuticals Co., Ltd. | Non-small Cell Lung Cancer, Brain Metastases | 06/13 | 12/13 | | |
